NUVB
NUVATION BIO-A (NUVB)
NYSE
$6.91-$0.02 (-0.26%)
Price as of Aug 21, 2026 7:50 PM EDT
  • $2.4B
    Market Cap
  • 138.97%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
FMR LLC
15.04%
52.2M
+240,702 (+0.46%)
Jun 30, 2026
BLACKROCK, INC.
7.96%
27.6M
+2.5M (+9.16%)
Jun 30, 2026
DECHENG CAPITAL LLC
7.48%
26.0M
0 (0.00%)
Jun 30, 2026
OMEGA FUND MANAGEMENT (US) INC.
6.61%
23.0M
-5.3M (-22.89%)
Dec 31, 2021
BLACKROCK FUNDING, INC. /DE
5.34%
18.5M
+1.6M (+8.46%)
Dec 31, 2024
BLACKROCK INC.
4.68%
16.2M
+3.7M (+22.84%)
Jun 30, 2024
VANGUARD GROUP INC
4.48%
15.6M
+101,011 (+0.65%)
Dec 31, 2025

Current Ownership Distribution

  • Institutions3.4B (81.80%)
  • Mutual Funds689.1M (16.63%)
  • Insiders65.2M (1.57%)
  • Other0 (0.00%)

Insider Transactions

  • 1.57% (65.2M)
    Current InsiderOwnership (%, shares)
  • 1
    Number of InsiderBuying (last 12 months)
  • $946,000.00
    Amount of InsiderBuying (last 12 months)
  • 4
    Number of InsiderSelling (last 12 months)
  • $5.0M
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Hattersley Gary
CHIEF SCIENTIFIC OFFICER
Exempt
Aug 19, 2026
$0.00
100,000
$0.00
400,000
Hattersley Gary
CHIEF SCIENTIFIC OFFICER
Exempt
Aug 19, 2026
$187,000.00
100,000
$1.87
100,000
Hattersley Gary
CHIEF SCIENTIFIC OFFICER
Sell
Aug 19, 2026
$709,240.00
100,000
$7.09
0
Sauvage Philippe
Chief Financial Officer
Exempt
Jul 15, 2026
$0.00
39,999
$0.00
662,333
Sauvage Philippe
Chief Financial Officer
Exempt
Jul 15, 2026
$0.00
1
$0.00
499,999
Sauvage Philippe
Chief Financial Officer
Exempt
Jul 15, 2026
$86,797.83
39,999
$2.17
54,130
Sauvage Philippe
Chief Financial Officer
Exempt
Jul 15, 2026
$1.97
1
$1.97
54,131
Sauvage Philippe
Chief Financial Officer
Exempt
Jun 23, 2026
$0.00
47,668
$0.00
702,332
Wentworth Kerry
CHIEF REGULATORY OFFICER
Exempt
Jun 23, 2026
$0.00
63,000
$0.00
152,250
Sauvage Philippe
Chief Financial Officer
Exempt
Jun 23, 2026
$103,439.56
47,668
$2.17
60,341
Wentworth Kerry
CHIEF REGULATORY OFFICER
Exempt
Jun 23, 2026
$184,590.00
63,000
$2.93
116,000
Sauvage Philippe
Chief Financial Officer
Sell
Jun 23, 2026
$286,370.28
47,668
$6.01
12,673
Wentworth Kerry
CHIEF REGULATORY OFFICER
Sell
Jun 23, 2026
$379,190.70
63,000
$6.02
53,000
Mashal Robert
Buy
Jun 09, 2026
$118,250.00
25,000
$4.73
225,000
Wentworth Kerry
CHIEF REGULATORY OFFICER
Exempt
Apr 06, 2026
$0.00
100,000
$0.00
400,000
Wentworth Kerry
CHIEF REGULATORY OFFICER
Exempt
Apr 06, 2026
$0.00
100,000
$0.00
300,000
Wentworth Kerry
CHIEF REGULATORY OFFICER
Exempt
Apr 06, 2026
$187,000.00
100,000
$1.87
153,000
Wentworth Kerry
CHIEF REGULATORY OFFICER
Exempt
Apr 06, 2026
$194,000.00
100,000
$1.94
253,000
Wentworth Kerry
CHIEF REGULATORY OFFICER
Sell
Apr 06, 2026
$903,560.00
200,000
$4.52
53,000
Wentworth Kerry
CHIEF REGULATORY OFFICER
Award
Feb 27, 2026
$0.00
748,130
$0.00
748,130
Hanley David C.
CHIEF TECHNICAL OPERATIONS
Award
Feb 27, 2026
$0.00
748,130
$0.00
748,130
Hung David
PRESIDENT AND CEO
Award
Feb 27, 2026
$0.00
2.0M
$0.00
2.0M
Liu Dongfang
CHIEF MEDICAL OFFICER
Award
Feb 27, 2026
$0.00
748,130
$0.00
748,130
Sauvage Philippe
Chief Financial Officer
Award
Feb 27, 2026
$0.00
748,130
$0.00
748,130
Makunje Moses
SEE REMARKS
Award
Feb 27, 2026
$0.00
224,439
$0.00
224,439
Makunje Moses
SEE REMARKS
Award
Feb 27, 2026
$0.00
50,761
$0.00
68,137
Liu Dongfang
CHIEF MEDICAL OFFICER
Exempt
Nov 26, 2025
$0.00
10,000
$0.00
470,000
Liu Dongfang
CHIEF MEDICAL OFFICER
Exempt
Nov 26, 2025
$36,100.00
10,000
$3.61
28,000
Liu Dongfang
CHIEF MEDICAL OFFICER
Sell
Nov 26, 2025
$80,000.00
10,000
$8.00
18,000
Liu Dongfang
CHIEF MEDICAL OFFICER
Exempt
Nov 25, 2025
$36,100.00
10,000
$3.61
28,000